Skip to main content

RHUMBLINE ADVISERS

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1115418 BOSTON, MA

Position in CRNX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$4,301,014
-$1,087,241 QoQ
Shares Held
118,420
+2.3% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 21.13663232562067.ToString("F0")% Shared 0.ToString("F0")% None 78.86336767437932.ToString("F0")%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,238,262,141 across 282 Biotechnology names. CRNX ranks #50 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRNX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,301,014 118,420
2025-12-31 $5,388,255 115,752
2025-09-30 $5,477,891 131,522
2025-06-30 $3,891,429 135,307
2025-03-31 $4,425,603 131,950
2024-12-31 $6,344,108 124,078
2024-09-30 $5,555,540 108,719
2024-06-30 $5,030,768 112,319
2024-03-31 $5,087,919 108,693
2023-12-31 $3,814,709 107,215
2023-09-30 $3,168,915 106,554
2023-06-30 $1,624,575 90,154
2023-03-31 $1,315,378 81,904
2022-12-31 $1,445,480 78,988
2022-09-30 $1,551,461 78,995
2022-06-30 $1,371,819 73,556
2022-03-31 $1,047,036 47,701
2021-12-31 $1,222,965 43,047
2021-09-30 $745,233 35,403
2021-06-30 $632,436 33,551
2021-03-31 $433,906 28,397
2020-12-31 $434,122 30,767
2020-09-30 $438,556 27,987
2020-06-30 $572,150 32,657
2020-03-31 $186,660 12,698